Julia W Gargano, Megan Wallace, Stephen C Hadler, Gayle Langley, John R Su, Matthew E Oster, Karen R Broder, Julianne Gee, Eric Weintraub, Tom Shimabukuro, Heather M Scobie, Danielle Moulia, Lauri E Markowitz, Melinda Wharton, Veronica V McNally, José R Romero, H Keipp Talbot, Grace M Lee, Matthew F Daley, Sara E Oliver
In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine and the Moderna COVID-19 (mRNA-1273) vaccine,† and the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for their use in persons aged ≥16 years and ≥18 years, respectively.§ In May 2021, FDA expanded the EUA for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; ACIP recommends that all persons aged ≥12 years receive a COVID-19 vaccine...
July 9, 2021: MMWR. Morbidity and Mortality Weekly Report